Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Update: A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects [Phase 3]
Phase III trial evaluating the efficacy and safety of MC2-01 cream compared with CAL/BDP gel and vehicle in plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Update: A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis [Phase 3]
A Phase 3 pediatric trial evaluating apremilast in children with mild to moderate plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 bioequivalence study comparing two treatments for plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]
Phase 2 trial results for LY4100511 (DC-853) in adults with moderate-to-severe plaque psoriasis have been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) [Phase 2]
Phase 2 trial results for ARQ-151 in children with plaque psoriasis (plaque psoriasis) evaluating maximal usage pharmacokinetics and safety;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating pharmacokinetics, safety, and effectiveness of certolizumab pegol in children with chronic plaque psoriasis is comp…
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis [Phase 2]
Phase 2 trial results for TLL018 in moderate-to-severe plaque psoriasis, reporting efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Update: A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating apremilast for safety and efficacy in Japanese children with moderate to severe plaque psoriasis; status indicates …
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis [Phase 3]
Phase 3 study assessing guselkumab in skin of color participants with moderate-to-severe plaque and/or scalp psoriasis has completed with re…
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy [Phase 2]
Phase 2 clinical trial examining skin transcriptional profiles in chronic plaque psoriasis patients treated with adalimumab biotherapy.
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: Guselkumab Immunogenetics [Phase 4]
Phase 4 clinical trial results for guselkumab in psoriasis conditions have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 clinical trial evaluating pharmacokinetics, safety, and effectiveness of certolizumab pegol in children with chronic plaque psoriasi…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Results: A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients [Phase 4]
Phase 4 trial evaluating topical skincare products for efficacy and tolerability in plaque psoriasis and psoriasis patients; results posted …
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 trial evaluates the efficacy and safety of JNJ-77242113 versus placebo and ustekinumab in moderate to severe plaque psoriasis; sta…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 3]
Phase 3 clinical trial update for TAK-279 in adults with moderate-to-severe plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight [Phase 4]
Phase 4 clinical trial comparing an adjusted brodalumab dose with the standard dose in adults with moderate-to-severe plaque psoriasis and b…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis. [Phase 1]
A Phase 1 study comparing Tapinarof Cream 1% and Vtama Cream 1% in the treatment of plaque psoriasis has completed, evaluating safety and pr…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Bimekizumab in Plaque Psoriasis [Phase 4]
A Phase 4 clinical trial evaluating bimekizumab for plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body) [Phase 4]
A Phase 4 head-to-head trial comparing risankizumab with deucravacitinib in moderate plaque psoriasis has completed, aiming to compare safet…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 study evaluating the efficacy and safety of netakimab in Chinese patients with moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis [Phase 4]
This document describes a Phase 4 clinical trial evaluating adalimumab for severe plaque psoriasis in Chinese children, which has not yet st…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
This clinical trial update reports the Phase 3 study of ESK-001 evaluating its efficacy and safety in patients with moderate to severe plaqu…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis [Phase 3]
This Phase 3 trial update presents long-term safety and efficacy data for ESK-001 in adults with moderate-to-severe plaque psoriasis; the st…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 [Phase 3]
Phase 3 study evaluating ESK-001 for moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis [Phase 4]
Phase 4 safety and pharmacokinetics study evaluating IDP-118 Lotion in pediatric participants with plaque psoriasis has been completed.